UK watchdog publishes key questions in Alliance Medical, IBA Molecular merger
MLex Summary: The UK’s Competition and Markets Authority has outlined the key questions in its review of Alliance Medical’s acquisition of medical-diagnosis assets from IBA Molecular. The target company makes a...To view the full article, register now.
Already a subscriber? Click here to view full article